IP Library Granted Patent US 9,273,071
Granted Patent B2
US 9,273,071 · App. 14/560,979 · Granted Mar 1, 2016

Zinc oxide complexes

Inventor: James Swanzy (Arlington, TX)
Assignee: Mary Kay Inc.
C07F3/06A61K8/27A61K8/35A61K8/58A61Q19/00A61Q19/02A61Q19/08C07F3/003A61K2800/10A61K2800/58A61Q1/02A61Q3/00A61Q5/02A61Q5/12A61Q17/04A61Q19/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,273,071
App. No.
14/560,979
Granted
Mar 1, 2016
Kind
B2
Abstract

Disclosed are compounds and methods of making said compounds comprising a zinc oxide molecule chemically bound to one or more molecules having an acidic hydrogen, such as an organic acid. The invention also provides compositions comprising such compounds and methods of preparing such compounds. The compounds of the invention may be provided in, for example, topical skin formulations, pharmaceutical compositions, or delivery systems for active ingredients.

Claims (11)

1. A salicylic acid/zinc oxide complex having the formula of:

wherein R 1 is hydrogen or a zinc oxide complex, R 2 is hydrogen or a zinc oxide complex, and at least one of R 1 and R 2 is a zinc oxide complex.

2. The salicylic acid/zinc oxide complex of claim 1 , wherein the salicylic acid/zinc oxide complex is in crystal form.

3. The salicylic acid/zinc oxide complex of claim 1 , wherein the salicylic acid/zinc oxide complex is comprised in a topical skin composition.

4. The salicylic acid/zinc oxide complex of claim 3 , wherein the topical skin composition is a cream, lotion, or gel.

5. The salicylic acid/zinc oxide complex of claim 3 , wherein the topical skin composition is an emulsion.

6. An alpha-hydroxy acid/zinc oxide complex having the formula of:

wherein R 1 is hydrogen or a zinc oxide complex, R 2 is hydrogen or a zinc oxide complex, R 3 is hydrogen or a zinc oxide complex, and R 4 is hydrogen or a zinc oxide complex, and at least one of R 1 , R 2 , R 3 and R 4 is a zinc oxide complex.

7. The alpha-hydroxy acid/zinc oxide complex of claim 6 , wherein the alpha-hydroxy acid/zinc oxide complex is a lactic acid/zinc oxide complex having the formula of:

8. The alpha-hydroxy acid/zinc oxide complex of claim 6 , wherein the alpha-hydroxy acid/zinc-oxide complex is a glycolic acid/zinc-oxide complex having the formula of:

9. The alpha-hydroxy acid/zinc oxide complex of claim 6 , wherein the alpha-hydroxy acid/zinc oxide complex is a citric acid/zinc-oxide complex having the formula of:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2014
From: SWANZY, JAMES
To: MARY KAY INC.
Reel/Frame 034380/0724 →
Continuity (4)
Continuation 13770317 · Feb 19, 2013
Continuation 13285807 · Oct 31, 2011
Provisional Application 61408307 · Oct 29, 2010
Related Publication 20150175630A1 · Jun 25, 2015